Procyon Advisors, LLC Jazz Pharmaceuticals PLC Transaction History

Procyon Advisors, LLC

  • $1.54 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 22, 2020
SELL
$105.46 - $144.13 $1,370 - $1,873
-13 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$95.68 - $121.88 $39,994 - $50,945
-418 Reduced 96.98%
13 $1,000
Q1 2020

May 15, 2020
SELL
$87.74 - $152.74 $50,187 - $87,367
-572 Reduced 57.03%
431 $43,000
Q4 2019

Feb 21, 2020
BUY
$117.65 - $153.73 $118,002 - $154,191
1,003 New
1,003 $150,000

Others Institutions Holding JAZZ

# of Institutions
540
Shares Held
59.6M
Call Options Held
136K
Put Options Held
64K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $8.4B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Procyon Advisors, LLC Portfolio

Follow Procyon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email